<DOC>
	<DOC>NCT00092469</DOC>
	<brief_summary>The purpose of this study is to evaluate the safety, tolerability, and immune response of an investigational vaccine being evaluated to reduce the incidence of diphtheria, pertussis, tetanus, hepatitis B, poliomyelitis, and Haemophilus influenza type b.</brief_summary>
	<brief_title>Study of an Investigational Vaccine in Healthy Infants in Taiwan (V441-001)(COMPLETED)</brief_title>
	<detailed_description>The duration of treatment is 65 weeks.</detailed_description>
	<mesh_term>Hepatitis B</mesh_term>
	<mesh_term>Diphtheria</mesh_term>
	<mesh_term>Poliomyelitis</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Healthy infant who received Hepatitis B vaccine within 5 days of birth and whose mother is negative to Hepatitis B surface antigen Problems with immune system Recent illness with fever</criteria>
	<gender>All</gender>
	<minimum_age>6 Weeks</minimum_age>
	<maximum_age>8 Weeks</maximum_age>
	<verification_date>October 2015</verification_date>
</DOC>